Stoke Therapeutics, Inc. (STOK) Operating margin 2022–2025
Stoke Therapeutics, Inc. (STOK) operating margin by fiscal year — reported operating income divided by reported revenue.
-11.2%FY2025 · since FY2022: -841.2% → -11.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -11.2% | +266.1 pp |
| FY2024 | -277.3% | +1029.9 pp |
| FY2023 | -1307.2% | -466.0 pp |
| FY2022 | -841.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More STOK financial trends
STOK RevenueSTOK Net incomeSTOK Net marginSTOK Gross profitSTOK Gross marginSTOK Operating incomeSTOK Operating cash flowSTOK Free cash flowSTOK Capital expendituresSTOK Return on equitySTOK Stock buybacksSTOK Dividends paidSTOK Total assetsSTOK Total liabilitiesSTOK Shareholders’ equitySTOK overview →